Minai-Azary Jennifer Lynn

Minai-Azary Jennifer Lynn is listed in filings as Chief Financial Officer at Context Therapeutics Inc.. This profile follows SEC Form 4 activity through Feb 23, 2026, including purchase activity. Recent filings connect the profile to Context Therapeutics Inc. (CNTX). The current snapshot covers public activity from Feb 14, 2025 to Feb 23, 2026. Reported amounts are shown as $638.0K to $301.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.